Palantir Technologies' stock has fallen nearly 11% year-to-date in 2026, validating investor Michael Burry's bearish position established via put options in late 2025. Despite the stock decline, Palantir's business continues to grow strongly, with revenue up 85% year-over-year in Q1 2026 and the CEO reporting the business nearly doubled in 12 months. Burry's short thesis focuses on the stock's high valuation driven by optimistic AI growth expectations. The stock's recent drop contrasts with the company's solid financial performance, highlighting the tension between market valuation and business fundamentals.
Palantir Technologies reported strong Q2 2026 results, exceeding revenue estimates by 7% and achieving a combined growth and margin metric of 155%. The company’s AI platform is well-positioned to benefit from accelerating enterprise AI adoption, whic...
The AI bubble is bursting as enterprises increasingly adopt sovereign AI platforms like Palantir's AIS, which allow full control over AI adoption and favor cheaper, open-weight models over expensive, closed-weight models used by hyperscalers. This sh...
During the Q2 earnings season, Palantir and Amazon stood out with impressive results driven by artificial intelligence demand. Palantir reported a 93% revenue increase to $1.94 billion and raised its full-year revenue forecast to $8.15 billion, highl...
Palantir's stock was nearly flat over the past year, rising just 1.24%, yet the GraniteShares 2x Long PLTR Daily ETF (PTIR) tracking it dropped 33.27%. This discrepancy is due to volatility decay inherent in daily-reset leveraged ETFs, which can lose...
Stocks fell sharply due to various factors including a 58.71% drop in the Defiance Daily Target 2x Short PLTR ETF, driven by strong gains in Palantir Technologies, which the ETF inversely tracks. AdaptHealth shares dropped 38.09% amid a legal investi...
